Related Experiment Video
Updated: Jan 30, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
The Transcriptional Regulator Sin3A Contributes to the Oncogenic Potential of STAT3
Giovanni Gambi1, Elisabetta Di Simone1, Veronica Basso1
1Division of Immunology, Transplantation and Infectious Disease, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Abstract:
Epigenetic silencing of promoter and enhancer regions is a common phenomenon in malignant cells. The transcription factor STAT3 is aberrantly activated in several tumors, where its constitutive acetylation accounts for the transcriptional repression of a number of tumor suppressor genes (TSG) via molecular mechanisms that remain to be understood. Using nucleophosmin-anaplastic lymphoma kinase-positive (NPM-ALK+) anaplastic large-cell lymphoma (ALCL) as model system, we found in cells and patient-derived tumor xenografts that STAT3 is constitutively acetylated as a result of ALK activity. STAT3 acetylation relied on intact ALK-induced PI3K- and mTORC1-dependent signaling and was sensitive to resveratrol. Resveratrol lowered STAT3 acetylation, rescued TSG expression, and induced ALCL apoptotic cell death. STAT3 constitutively bound the Sin3A transcriptional repressor complex, and both STAT3 and Sin3A bound the promoter region of silenced TSG via a resveratrol-sensitive mechanism. Silencing SIN3A caused reexpression of TSG, induced ALCL apoptotic cell death in vitro, and hindered ALCL tumorigenic potential in vivo. A constitutive STAT3-Sin3A interaction was also found in breast adenocarcinoma cells and proved critical for TSG silencing and cell survival. Collectively, these results suggest that oncogene-driven STAT3 acetylation and its constitutive association with Sin3A represent novel and concomitant events contributing to STAT3 oncogenic potential. SIGNIFICANCE: This study delineates the transcriptional regulatory complex Sin3A as a mediator of STAT3 transcriptional repressor activity and identifies the STAT3/Sin3A axis as a druggable target to antagonize STAT3-addicted tumors. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/79/12/3076/F1.large.jpg.See related commentary by Monteleone and Poli, p. 3031.
Insights
Oncogene-driven STAT3 acetylation, mediated by the Sin3A complex, silences tumor suppressor genes in cancer. Targeting this STAT3/Sin3A axis offers a new therapeutic strategy for STAT3-addicted tumors.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Malignant cells frequently exhibit epigenetic silencing of key gene regulatory regions.
- Aberrant activation of Signal Transducer and Activator of Transcription 3 (STAT3) is common in various cancers.
- The precise mechanisms by which STAT3's constitutive acetylation leads to tumor suppressor gene (TSG) repression remain unclear.
Purpose of the Study:
- To investigate the molecular mechanisms underlying STAT3-mediated transcriptional repression in cancer.
- To identify novel therapeutic targets for STAT3-dependent malignancies.
Main Methods:
- Utilized NPM-ALK+ anaplastic large-cell lymphoma (ALCL) as a model system.
- Employed patient-derived tumor xenografts for in vivo validation.
- Investigated the role of STAT3 acetylation, PI3K/mTORC1 signaling, resveratrol treatment, and STAT3-Sin3A complex interactions.
Main Results:
- Constitutive STAT3 acetylation, driven by ALK activity, was observed in ALCL cells and xenografts.
- Resveratrol treatment reduced STAT3 acetylation, restored TSG expression, and induced apoptosis.
- STAT3 constitutively interacts with the Sin3A repressor complex, binding to silenced TSG promoters in a resveratrol-sensitive manner.
- Silencing SIN3A reactivated TSG, induced apoptosis, and reduced tumorigenicity.
- A similar STAT3-Sin3A interaction was identified in breast adenocarcinoma cells, crucial for TSG silencing and survival.
Conclusions:
- Oncogene-driven STAT3 acetylation and its constitutive association with Sin3A are key contributors to STAT3's oncogenic activity.
- The Sin3A complex acts as a mediator of STAT3's transcriptional repressor function.
- The STAT3/Sin3A axis represents a druggable target for treating STAT3-addicted cancers.
More Related Videos
Related Concept Videos
Master Transcription Regulators
Master Transcription Regulators
Cooperative Binding of Transcription Regulators
Cooperative Binding of Transcription Regulators
Transcriptional Regulation: Riboswitches
Transcription Factors

